Global Pet Allergy Treatment Market Forecast
- Global pet allergy treatment market size to reach US$3.8 Bn in 2031, up from US$2.2 Bn posed by the end of 2024
- Market revenue projected to exhibit a remarkable rate of expansion, at an estimated CAGR of 8.12% during 2024 - 2031
Quick Report Digest
- Global pet allergy treatment market projected to reach US$3.8 billion by 2031, with a CAGR of 8.12% from 2024 to 2031.
- Market driven by increasing pet ownership, technological advancements, and growing awareness about pet allergies.
- Segmented by product type, distribution channel, pet type, and region.
- North America, and Europe lead the market, while Asia Pacific shows fastest growth.
- Challenges include accessibility issues, regulatory hurdles, and lack of awareness.
- Opportunities lie in telecommuting, sustainability initiatives, and novel therapies.
- Stringent regulations impact market dynamics, ensuring safety but hindering innovation.
- Top segments include allergen immunotherapy, antihistamines, and corticosteroids.
- Leading companies include Zoetis, Merck and Co. Inc., and Boehringer Ingelheim.
- Market segmented by drug class, indication, pet type, route of administration, distribution channel, and region.
A Look Back and a Look Forward - Comparative Analysis
The pet allergy treatment market has soared between 2019 and 2023, fueled by a confluence of factors. More people are welcoming pets into their homes, sparking a demand for allergy solutions. Public awareness of pet allergies and their management has risen significantly. Additionally, advancements in immunotherapy and medication have brought more effective and convenient treatments to the market. This trend is expected to persist throughout the forecast period (2024-2031).
Several forces are poised to propel the market forward. The global rise in pet ownership continues to create a need for allergy treatments. As disposable income increases, pet owners are more likely to invest in pet healthcare, including allergy solutions. Furthermore, innovation in immunotherapy and medication is creating more effective and convenient treatment options. This, coupled with growing public awareness of pet allergies and their management, is propelling market growth.
The market is segmented by product type, distribution channel, and pet type. This allows for a nuanced understanding of consumer preferences and industry trends. Geographically, North America and Europe are expected to remain dominant markets due to their high pet ownership rates and advanced healthcare infrastructure. However, the Asia Pacific region is anticipated to witness the fastest growth. Rising disposable income and increasing pet ownership in this region are creating significant opportunities for market expansion.
Key Growth Determinants
- Increasing Pet Ownership
The rising trend of pet ownership, particularly in urban areas, is a significant driver for the pet allergy treatment market. As more households include pets, there's a proportional increase in the prevalence of pet allergies, necessitating the demand for effective treatments.
- Technological Advancements
Ongoing advancements in allergy diagnosis and treatment technologies are enhancing the efficacy and convenience of pet allergy treatments. Innovations such as allergen-specific immunotherapy, molecular diagnostics, and targeted therapies are driving market growth by offering more precise and personalised solutions for pet allergy sufferers.
- Growing Awareness and Education
Heightened awareness about pet allergies among both pet owners and healthcare professionals is contributing to market expansion. Increased education about allergy symptoms, triggers, and available treatment options is encouraging more individuals to seek diagnosis and management strategies, thereby fueling the demand for pet allergy treatments. Moreover, campaigns by allergy organisations and pet industry stakeholders are furthering understanding and recognition of the importance of managing pet allergies effectively.
Major Growth Barriers
- Limited Accessibility
Accessibility to pet allergy treatments may be restricted due to various factors such as geographical location, economic disparities, and healthcare infrastructure. In regions with limited access to specialised healthcare services, individuals may face challenges in obtaining proper diagnosis and treatment for pet allergies.
- Regulatory Hurdles
Stringent regulatory requirements and approval processes can act as significant barriers to the growth of the pet allergy treatment market. Developing and bringing new treatments to market often requires extensive clinical trials and regulatory approvals, which can be time-consuming and costly for pharmaceutical companies.
- Lack of Awareness
Despite the prevalence of pet allergies, there remains a significant lack of awareness among the general population regarding available treatment options. Many individuals may not realise that effective treatments exist or may underestimate the severity of their symptoms, leading to underutilisation of pet allergy treatments and hindering market growth.
Key Trends and Opportunities to Look at
- Telecommuting
The COVID-19 pandemic accelerated the adoption of remote work, leading to a significant increase in telecommuting across various sectors. This trend has reshaped the way businesses operate, with many companies adopting remote work policies either partially or entirely. As a result, there has been a surge in demand for technologies and services that facilitate remote collaboration, such as video conferencing platforms, project management tools, and cybersecurity solutions. Additionally, the shift towards remote work has prompted organisations to reevaluate their real estate needs, potentially leading to long-term changes in office space utilisation and commercial real estate markets.
- Sustainability
With growing concerns about climate change and environmental degradation, consumers are increasingly prioritizing sustainability when making purchasing decisions. This trend is driving demand for eco-friendly products and practices across various industries, including fashion, food and beverage, and manufacturing. Companies are responding by adopting sustainable sourcing practices, reducing waste, and developing innovative green technologies. Moreover, investors are increasingly considering environmental, social, and governance (ESG) factors when evaluating investment opportunities, further incentivizing businesses to prioritise sustainability.
- Development of Novel Therapies
There is a growing need for more effective and convenient treatments for pet allergies. Market players have an opportunity to capitalise on this demand by investing in research and development to create novel therapies that provide long-lasting relief with minimal side effects. This could involve the development of new pharmaceutical drugs, biologics, or immunotherapies tailored specifically for pet allergies. Additionally, advancements in gene editing technologies may offer new avenues for targeted treatments that address the underlying mechanisms of pet allergies.
- Expansion of Allergy Management Solutions
Beyond pharmaceutical treatments, there is a need for comprehensive allergy management solutions that encompass preventive measures, symptom management, and lifestyle modifications. Market players can seize this opportunity by offering integrated solutions that combine pharmaceutical treatments with allergen avoidance strategies, allergen immunotherapy, and patient education programs. Moreover, there is potential for the development of innovative devices or digital health platforms that enable remote monitoring of allergy symptoms, personalised treatment plans, and telemedicine consultations with allergists.
How Does the Regulatory Scenario Shape this Industry?
The regulatory landscape significantly impacts the pet allergy treatments market. Stringent regulations by agencies like the US Food and Drug Administration (FDA) ensure safety and efficacy before a treatment reaches consumers. This can be a hurdle for new innovations, potentially delaying market entry and increasing development costs for companies. However, these regulations also build trust in the market. Consumers are confident that approved treatments have undergone rigorous testing and are less likely to cause adverse effects.
Furthermore, regulations often dictate the types of pet allergy treatments that can be developed. Restrictions on genetically modified organisms (GMOs) or certain ingredients could limit the options available to researchers. Conversely, regulations can also incentivise specific treatment approaches. Fast-track approvals for breakthrough therapies or orphan drugs (treatments for rare conditions, including some pet allergies) can accelerate development and bring relief to allergy sufferers faster.
Regulatory bodies also play a role in monitoring post-market safety. This ensures that even approved treatments continue to be safe for long-term use. If safety concerns arise, regulators can mandate recalls or even remove a product from the market entirely. This protects consumers but can also lead to market uncertainty for companies.
Overall, the regulatory scenario plays a complex role in shaping the pet allergy treatments market. While it can slow down innovation and restrict options, it also ensures safety, builds trust, and can even incentivise development in specific areas. The constant interplay between regulatory bodies, pharmaceutical companies, and consumer needs shapes the future of this ever-evolving market.
Fairfield’s Ranking Board
Top Segments
- Allergen Immunotherapy (AIT) Products Lead
Allergen immunotherapy, including subcutaneous and sublingual formulations, remains a cornerstone in pet allergy treatment. These products work by exposing patients to gradually increasing doses of allergens, desensitizing their immune systems. With advancements in formulation and delivery methods, such as fast-dissolving sublingual tablets, AIT has seen increased acceptance and compliance among patients. Moreover, the growing demand for personalised medicine has driven the development of tailored allergen mixes, enhancing efficacy and minimizing adverse reactions. Additionally, the potential for disease modification, wherein AIT not only alleviates symptoms but also alters the underlying immune response, adds to its appeal among healthcare providers and patients alike.
- Dominance of Antihistamines and Corticosteroids Prevails
Antihistamines and corticosteroids continue to dominate the symptomatic management of pet allergies. These drugs provide rapid relief from itching, sneezing, and other allergic symptoms by blocking histamine receptors or suppressing inflammation. The availability of newer generation antihistamines with improved safety profiles and once-daily dosing regimens has increased patient adherence. However, concerns regarding long-term corticosteroid use, including systemic side effects and potential for rebound symptoms upon discontinuation, highlight the need for alternative treatment options. Nonetheless, their widespread availability as over-the-counter medications ensures accessibility to patients seeking immediate relief from pet allergy symptoms.
- Biologic Therapies Gain Traction
Biologic therapies represent a promising avenue for severe or refractory cases of pet allergies. Monoclonal antibodies targeting specific components of the allergic cascade, such as IgE or pro-inflammatory cytokines, offer targeted and potent suppression of allergic reactions. These biologics have demonstrated efficacy in reducing symptom severity and reliance on rescue medications, thus improving quality of life for affected individuals. Furthermore, their mechanism of action bypasses the need for allergen exposure, potentially appealing to patients seeking alternatives to traditional immunotherapy. However, challenges related to high treatment costs and the need for parenteral administration may limit widespread adoption, necessitating further research into cost-effective formulations and delivery methods.
Regional Frontrunners
North America's Dominance Continues in Global Pet Allergy Treatment Market
North America dominates the pet allergy treatment market due to several factors. Firstly, the region has a significant pet ownership rate, with dogs and cats being the most common pets. This high ownership contributes to a substantial demand for allergy treatments. Secondly, the region has a well-established healthcare infrastructure and a high level of awareness regarding pet allergies, leading to increased diagnosis and treatment.
Additionally, advancements in medical technology and research further bolster the market growth. Moreover, the presence of key market players and their focus on research and development activities contribute to the market's expansion. Overall, North America's strong market position in pet allergy treatment is attributed to its high pet ownership rates, advanced healthcare infrastructure, and continuous innovation in treatment methods.
Europe has a Growing Role in Global Market for Pet Allergy Treatments
Europe stands out as a significant market for pet allergy treatment, driven by various factors. Firstly, the region has a substantial pet ownership culture, particularly of cats and dogs. This high prevalence of pets contributes to the increasing demand for allergy treatment options. Secondly, Europe boasts advanced healthcare systems and widespread awareness about pet allergies among both pet owners and healthcare professionals.
This results in a higher rate of diagnosis and treatment seeking behaviour. Moreover, the presence of leading pharmaceutical companies investing in research and development further fuels market growth. Additionally, stringent regulatory frameworks ensure the safety and efficacy of allergy treatment products, enhancing consumer confidence. Overall, Europe's robust market for pet allergy treatment is characterised by high pet ownership rates, advanced healthcare infrastructure, and a supportive regulatory environment.
The Rise of Asia Pacific in Pet Allergy Treatment Market
Asia Pacific is witnessing significant growth in the pet allergy treatment market, propelled by several factors. Firstly, the region is experiencing a rise in pet ownership, driven by increasing urbanisation, rising disposable incomes, and changing lifestyles. This surge in pet ownership amplifies the demand for allergy treatment solutions. Secondly, awareness about pet allergies and their management is gradually increasing in countries across the region, leading to higher diagnosis rates and treatment seeking behaviour.
Furthermore, advancements in healthcare infrastructure and increased expenditure on pet healthcare contribute to market expansion. Additionally, the presence of key market players expanding their operations in the region further stimulates growth. Overall, Asia Pacific's burgeoning pet allergy treatment market is characterised by rising pet ownership, improving healthcare infrastructure, and growing awareness about pet allergies.
Fairfield’s Competitive Landscape Analysis
The pet allergy treatment market features a competitive landscape marked by the presence of several key players vying for market share. Leading companies in this space include Zoetis Inc., Virbac, Bayer AG, and Boehringer Ingelheim. These players employ various growth strategies to maintain their competitive edge.
One prevalent strategy is product innovation, where companies invest in research and development to introduce novel treatment options catering to different types of pet allergies. Additionally, strategic partnerships and collaborations are common approaches to expand market reach and enhance distribution networks.
Moreover, aggressive marketing tactics, including digital marketing and targeted advertising, play a crucial role in building brand awareness and driving consumer engagement. Overall, the market is dynamic, with companies continually striving to differentiate themselves through a combination of innovation, strategic alliances, and effective marketing strategies.
Who are the Leaders in the pet allergy treatment market Space?
- Zoetis Animal Healthcare
- Merck and Co. Inc. (US)
- Boehringer Ingelheim GmbH
- Elanco Animal Health Incorporated
- Bayer AG
- Vetoquinol S.A.
- Dechra Pharmaceuticals PLC
- Virbac SA
- IDEXX Laboratories, Inc.
- Ceva Santé Animale
- Kindred Biosciences, Inc.
- Phirbo Animal Health
- Norbrook Laboratories Limited
- Vetiquinol SA
- Neogen Corporation
- PetIQ, Inc.
- Huvepharma AD
- Chanelle Pharma Group Limited
- Kepro
- Biogénesis Bagó
Significant Company Developments
New Product Launch
- June 2023: In June 2023, a prominent player in the pet allergy treatment market unveiled a revolutionary hypoallergenic pet food formula. This innovative product is designed to mitigate allergic reactions in sensitive individuals while still providing essential nutrition for pets. Its unique composition aims to minimise allergen exposure, offering relief to pet owners with allergies without compromising their pets' well-being.
- September 2023: September 2023 witnessed the introduction of an advanced pet dander removal spray by a leading brand in the pet allergy treatment sector. This novel product utilises cutting-edge technology to effectively neutralise and remove pet dander from various surfaces, including furniture, carpets, and bedding. Its rapid action and long-lasting effects make it an indispensable solution for individuals seeking to alleviate allergic symptoms associated with pet dander exposure.
Distribution Agreement
- January 2024: In January 2024, a strategic distribution agreement was forged between two prominent companies specializing in pet allergy treatment solutions. This collaboration aims to expand the availability of allergy-friendly pet products, including hypoallergenic pet foods, grooming supplies, and air purifiers, to a wider consumer base. By leveraging each other's strengths and distribution networks, both parties seek to enhance accessibility to innovative pet allergy management solutions globally.
- March 2024: The signing of a significant distribution agreement within the pet allergy treatment market. This agreement saw the collaboration between a leading pharmaceutical company and a renowned e-commerce platform specializing in pet supplies. Through this partnership, the comprehensive range of pet allergy relief medications and specialised grooming products will be made readily accessible to consumers worldwide, ensuring greater convenience and efficacy in managing pet-related allergies.
An Expert’s Eye
- Promising Market Expansion:
Expert analysts are optimistic about the growth prospects of the global pet allergy treatment market. With the rising prevalence of pet allergies worldwide, there is a growing demand for effective treatments. Factors such as urbanisation, increased pet ownership, and heightened awareness about pet allergies contribute to market expansion. Additionally, advancements in biotechnology and immunotherapy offer innovative solutions, driving market growth. The increasing adoption of pets as companions in households across regions like North America, Europe, and Asia-Pacific further fuels market demand. Moreover, the emergence of novel therapies, including monoclonal antibodies and gene therapy, is expected to significantly impact market dynamics, providing new avenues for growth.
- Challenges and Opportunities:
Despite the promising outlook, the pet allergy treatment market faces challenges such as stringent regulatory requirements, high treatment costs, and limited accessibility in certain regions. Moreover, the COVID-19 pandemic has disrupted supply chains and affected healthcare services, posing temporary setbacks to market growth. However, analysts emphasize that these challenges also present opportunities for market players to innovate and diversify their product offerings. Collaborations between pharmaceutical companies, research institutions, and healthcare providers can accelerate the development and commercialisation of new treatments. Additionally, expanding market penetration in untapped regions and investing in marketing strategies to raise awareness about pet allergies and available treatments are key strategies for market players to capitalise on emerging opportunities and sustain growth in the global pet allergy treatment market.
The Global pet allergy treatment market is Segmented as Below:
By Drug Class:
- Antihistamines
- Corticosteroids
- Immunotherapy
- Antibiotics
By Indication:
- Allergic Dermatitis
- Food Allergy
- Fleabite Allergy
- Contact Allergy
By Pet Type:
- Dogs
- Cats
- Rodents & Rabbits
By Route of Administration:
- Oral
- Injectable
- Topical
By Distribution Channel:
- Veterinary Hospitals
- Retail Pharmacies
- Online Pharmacies
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
1. Executive Summary
1.1. Global Pet Allergy Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, By Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.8. PESTLE Analysis
3. Global Pet Allergy Treatment Market Outlook, 2019 - 2031
3.1. Global Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Antihistamines
3.1.1.2. Corticosteroids
3.1.1.3. Immunotherapy
3.1.1.4. Antibiotics
3.2. Global Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2019 - 2031
3.2.1. Key Highlights
3.2.1.1. Allergic Dermatitis
3.2.1.2. Food Allergy
3.2.1.3. Fleabite Allergy
3.2.1.4. Contact Allergy
3.3. Global Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2019 - 2031
3.3.1. Key Highlights
3.3.1.1. Dogs
3.3.1.2. Cats
3.3.1.3. Rodents and rabbits
3.4. Global Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2019 - 2031
3.4.1. Key Highlights
3.4.1.1. Oral
3.4.1.2. Injectable
3.4.1.3. Topical
3.5. Global Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2019 - 2031
3.5.1. Key Highlights
3.5.1.1. Veterinary Hospitals
3.5.1.2. Retail Pharmacies
3.5.1.3. Online Pharmacies
3.5.1.4. Others
3.6. Global Pet Allergy Treatment Market Outlook, By Region, Value (US$ Bn), 2019 - 2031
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa
4. North America Pet Allergy Treatment Market Outlook, 2019 - 2031
4.1. North America Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Antihistamines
4.1.1.2. Corticosteroids
4.1.1.3. Immunotherapy
4.1.1.4. Antibiotics
4.2. North America Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Allergic Dermatitis
4.2.1.2. Food Allergy
4.2.1.3. Fleabite Allergy
4.2.1.4. Contact Allergy
4.3. North America Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Dogs
4.3.1.2. Cats
4.3.1.3. Rodents and rabbits
4.4. North America Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. Oral
4.4.1.2. Injectable
4.4.1.3. Topical
4.5. North America Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2019 - 2031
4.5.1. Key Highlights
4.5.1.1. Veterinary Hospitals
4.5.1.2. Retail Pharmacies
4.5.1.3. Online Pharmacies
4.5.1.4. Other
4.6. North America Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2019 - 2031
4.6.1. Key Highlights
4.6.1.1. U.S. Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
4.6.1.2. U.S. Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
4.6.1.3. U.S. Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
4.6.1.4. U.S. Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
4.6.1.5. U.S. Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
4.6.1.6. Canada Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
4.6.1.7. Canada Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
4.6.1.8. Canada Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
4.6.1.9. Canada Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
4.6.1.10. Canada Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
4.6.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Pet Allergy Treatment Market Outlook, 2019 - 2031
5.1. Europe Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Antihistamines
5.1.1.2. Corticosteroids
5.1.1.3. Immunotherapy
5.1.1.4. Antibiotics
5.2. Europe Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Allergic Dermatitis
5.2.1.2. Food Allergy
5.2.1.3. Fleabite Allergy
5.2.1.4. Contact Allergy
5.3. Europe Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Dogs
5.3.1.2. Cats
5.3.1.3. Rodents and rabbits
5.4. Europe Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. Oral
5.4.1.2. Injectable
5.4.1.3. Topical
5.5. Europe Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2019 - 2031
5.5.1. Key Highlights
5.5.1.1. Veterinary Hospitals
5.5.1.2. Retail Pharmacies
5.5.1.3. Online Pharmacies
5.5.1.4. Other
5.6. Europe Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2019 - 2031
5.6.1. Key Highlights
5.6.1.1. Germany Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
5.6.1.2. Germany Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
5.6.1.3. Germany Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
5.6.1.4. Germany Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
5.6.1.5. Germany Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
5.6.1.6. U.K. Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
5.6.1.7. U.K. Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
5.6.1.8. U.K. Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
5.6.1.9. U.K. Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
5.6.1.10. U.K. Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
5.6.1.11. France Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
5.6.1.12. France Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
5.6.1.13. France Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
5.6.1.14. France Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
5.6.1.15. France Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
5.6.1.16. Italy Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
5.6.1.17. Italy Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
5.6.1.18. Italy Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
5.6.1.19. Italy Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
5.6.1.20. Italy Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
5.6.1.21. Russia Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
5.6.1.22. Russia Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
5.6.1.23. Russia Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
5.6.1.24. Russia Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
5.6.1.25. Russia Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
5.6.1.26. Rest of Europe Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
5.6.1.27. Rest of Europe Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
5.6.1.28. Rest of Europe Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
5.6.1.29. Rest of Europe Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
5.6.1.30. Rest of Europe Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
5.6.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Pet Allergy Treatment Market Outlook, 2019 - 2031
6.1. Asia Pacific Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Antihistamines
6.1.1.2. Corticosteroids
6.1.1.3. Immunotherapy
6.1.1.4. Antibiotics
6.2. Asia Pacific Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Allergic Dermatitis
6.2.1.2. Food Allergy
6.2.1.3. Fleabite Allergy
6.2.1.4. Contact Allergy
6.3. Asia Pacific Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Dogs
6.3.1.2. Cats
6.3.1.3. Rodents and rabbits
6.4. Asia Pacific Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. Oral
6.4.1.2. Injectable
6.4.1.3. Topical
6.5. Asia Pacific Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2019 - 2031
6.5.1. Key Highlights
6.5.1.1. Veterinary Hospitals
6.5.1.2. Retail Pharmacies
6.5.1.3. Online Pharmacies
6.5.1.4. Other
6.6. Asia Pacific Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2019 - 2031
6.6.1. Key Highlights
6.6.1.1. China Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
6.6.1.2. China Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
6.6.1.3. China Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
6.6.1.4. China Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
6.6.1.5. China Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
6.6.1.6. Japan Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
6.6.1.7. Japan Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
6.6.1.8. Japan Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
6.6.1.9. Japan Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
6.6.1.10. Japan Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
6.6.1.11. South Korea Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
6.6.1.12. South Korea Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
6.6.1.13. South Korea Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
6.6.1.14. South Korea Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
6.6.1.15. South Korea Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
6.6.1.16. India Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
6.6.1.17. India Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
6.6.1.18. India Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
6.6.1.19. India Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
6.6.1.20. India Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
6.6.1.21. Southeast Asia Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
6.6.1.22. Southeast Asia Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
6.6.1.23. Southeast Asia Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
6.6.1.24. Southeast Asia Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
6.6.1.25. Southeast Asia Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
6.6.1.26. Rest of Asia Pacific Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
6.6.1.27. Rest of Asia Pacific Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
6.6.1.28. Rest of Asia Pacific Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
6.6.1.29. Rest of Asia Pacific Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
6.6.1.30. Rest of Asia Pacific Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
6.6.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Pet Allergy Treatment Market Outlook, 2019 - 2031
7.1. Latin America Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Antihistamines
7.1.1.2. Corticosteroids
7.1.1.3. Immunotherapy
7.1.1.4. Antibiotics
7.2. Latin America Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2019 - 2031
7.2.1. Key Highlights
7.2.1.1. Allergic Dermatitis
7.2.1.2. Food Allergy
7.2.1.3. Fleabite Allergy
7.2.1.4. Contact Allergy
7.3. Latin America Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Dogs
7.3.1.2. Cats
7.3.1.3. Rodents and rabbits
7.4. Latin America Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Oral
7.4.1.2. Injectable
7.4.1.3. Topical
7.5. Latin America Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2019 - 2031
7.5.1. Key Highlights
7.5.1.1. Veterinary Hospitals
7.5.1.2. Retail Pharmacies
7.5.1.3. Online Pharmacies
7.5.1.4. Other
7.6. Latin America Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2019 - 2031
7.6.1. Key Highlights
7.6.1.1. Brazil Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
7.6.1.2. Brazil Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
7.6.1.3. Brazil Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
7.6.1.4. Brazil Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
7.6.1.5. Brazil Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
7.6.1.6. Mexico Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
7.6.1.7. Mexico Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
7.6.1.8. Mexico Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
7.6.1.9. Mexico Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
7.6.1.10. Mexico Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
7.6.1.11. Rest of Latin America Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
7.6.1.12. Rest of Latin America Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
7.6.1.13. Rest of Latin America Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
7.6.1.14. Rest of Latin America Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
7.6.1.15. Rest of Latin Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
7.6.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Pet Allergy Treatment Market Outlook, 2019 - 2031
8.1. Middle East & Africa Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Antihistamines
8.1.1.2. Corticosteroids
8.1.1.3. Immunotherapy
8.1.1.4. Antibiotics
8.2. Middle East & Africa Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Allergic Dermatitis
8.2.1.2. Food Allergy
8.2.1.3. Fleabite Allergy
8.2.1.4. Contact Allergy
8.3. Middle East & Africa Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2019 - 2031
8.3.1. Key Highlights
8.3.1.1. Dogs
8.3.1.2. Cats
8.3.1.3. Rodents and rabbits
8.4. Middle East & Africa Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. Oral
8.4.1.2. Injectable
8.4.1.3. Topical
8.5. Middle East & Africa Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2019 - 2031
8.5.1. Key Highlights
8.5.1.1. Veterinary Hospitals
8.5.1.2. Retail Pharmacies
8.5.1.3. Online Pharmacies
8.5.1.4. Others
8.6. Middle East & Africa Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2019 - 2031
8.6.1. Key Highlights
8.6.1.1. GCC Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
8.6.1.2. GCC Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
8.6.1.3. GCC Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
8.6.1.4. GCC Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
8.6.1.5. GCC Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
8.6.1.6. South Africa Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
8.6.1.7. South Africa Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
8.6.1.8. South Africa Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
8.6.1.9. South Africa Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
8.6.1.10. South Africa Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
8.6.1.11. Egypt Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
8.6.1.12. Egypt Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
8.6.1.13. Egypt Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
8.6.1.14. Egypt Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
8.6.1.15. Egypt Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
8.6.1.16. Rest of Middle East & Africa Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2019 - 2031
8.6.1.17. Rest of Middle East & Africa Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2019 - 2031
8.6.1.18. Rest of Middle East & Africa Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2019 - 2031
8.6.1.19. Rest of Middle East & Africa Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2019 - 2031
8.6.1.20. Rest of Middle East & Africa Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2019 - 2031
8.6.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Application Heatmap
9.2. Manufacturer vs Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Zoetis Animal Healthcare
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Merck and Co.Inc. (US)
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Boehringer Ingelheim GmbH
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Elanco Animal Health Incorporated
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Bayer AG
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Vetoquinol S.A.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Dechra Pharmaceuticals PLC
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Virbac SA
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Business Strategies and Development
9.5.9. IDEXX Laboratories, Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Ceva Santé Animale
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Kindred Biosciences, Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Phirbo Animal Health
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Norbrook Laboratories Limited
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Vetiquinol SA
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Neogen Corporation
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. PetIQ, Inc.
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. Huvepharma AD
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
9.5.18. Chanelle Pharma Group Limited
9.5.18.1. Company Overview
9.5.18.2. Product Portfolio
9.5.18.3. Financial Overview
9.5.18.4. Business Strategies and Development
9.5.19. Kepro
9.5.19.1. Company Overview
9.5.19.2. Product Portfolio
9.5.19.3. Financial Overview
9.5.19.4. Business Strategies and Development
9.5.20. Biogénesis Bagó
9.5.20.1. Company Overview
9.5.20.2. Product Portfolio
9.5.20.3. Financial Overview
9.5.20.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations
|
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
 |
2023 |
 |
2019 - 2023 |
 |
2024 - 2031 |
Value: US$ Billion |
|
REPORT FEATURES |
DETAILS |
|
Drug Class Coverage |
|
|
Indication Coverage |
|
|
Pet Coverage |
|
|
Route of Administration Coverage |
|
|
Distribution Channel Coverage |
|
|
Geographical Coverage |
|
|
Leading Companies |
|
|
Report Highlights |
Key Market Indicators, Macro-micro economic impact analysis, Technological Roadmap, Key Trends, Driver, Restraints, and Future Opportunities & Revenue Pockets, Porter’s 5 Forces Analysis, Historical Trend (2019-2021), Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Category, Region, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply Chain) |
Quality assured
